Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q2 2025 Earnings Call Transcript
Operator: Good morning, and welcome to Mersana Therapeutics Second Quarter 2025 Financial Results and Business Update Conference Call and Webcast.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Rock Springs Capital Management Kris Jenner, Gordon Bussard, Graham Mcphail | 152,586 | $4,414,313 | 0.23% | |
| 2. | Millennium Management Israel Englander | 63,305 | $1,831,414 | -19% | 0% |
| 3. | Rangeley Capital Christopher Demuth | 57,098 | $1,651,845 | 1.37% | |
| 4. | AQR Capital Management Cliff Asness | 37,264 | $1,078,047 | -21% | 0% |
| 5. | Citadel Investment Group Ken Griffin | 22,493 | $650,722 | 0% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.20 | 14,760 | $47,181.82 | 8,663,673 | 2022-06-02 | Filing | |
| $3.28 | 80,759 | $264,776.46 | 8,648,913 | 2022-05-31 | Filing | |
| $3.19 | 75,000 | $238,942.50 | 8,568,154 | 2022-05-26 | Filing | |
| $3.18 | 90,155 | $286,242.13 | 8,493,154 | 2022-05-25 | Filing | |
| $3.29 | 100,000 | $328,990.00 | 8,402,999 | 2022-05-24 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.90 | 77 | $762.30 | 2,922 | 2025-10-27 | Filing | |
| $7.31 | 2,012 | $14,707.72 | 9,572 | 2025-09-12 | Filing | |
| $0.58 | 3,554 | $2,061.32 | 57,519 | 2025-01-16 | Filing | |
| $0.58 | 8,637 | $5,009.46 | 168,041 | 2025-01-16 | Filing | |
| $0.58 | 8,048 | $4,667.84 | 257,673 | 2025-01-16 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 482,689 | $13,964,193 | 1.35% | |
| 2. | 346,545 | $10,025,547 | 0.77% | |
| 3. | 210,301 | $6,084,008 | 0% | |
| 4. | 24,165 | $3,336,994 | 2.25% | |
| 5. | 100,000 | $2,893,000 | 0.16% |